Education
About Us
Working with TipRanks
Follow Us
Clover Health Investments (CLOV)
NASDAQ:CLOV
CLOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.12 - $4.87
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.37M
Market Cap
$1.65B
Enterprise Value$1.42B
Total Cash (Recent Filing)$199.50M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Nov 10, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding420,139,400
10 Day Avg. Volume6,085,683
30 Day Avg. Volume5,365,901
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)4.52
Price to Sales (P/S)1.13
P/FCF Ratio46.37
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit3.70
Enterprise Value/Ebitda-35.00
Forecast
1Y Price Target
$3.65Price Target Upside15.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Membership GrowthManagement believes the company could accelerate membership in 2026 from the already robust ~28% growth at the midpoint of 2025 membership guidance.
Operational EfficiencyClover maintained profitability through a continuation of SG&A leverage.
Revenue GrowthThe MA rates announced, contemplating an effective average growth rate of 9.04%, should be a significant tailwind to revenue.
Bears Say
Drug CostsA concern came from higher utilization in Part D drug spend, with member out-of-pocket costs capped at $2,000 per year, potentially increasing liability for the plans.
Insurance ExpensesThe insurance benefit expense ratio came in higher than estimates, causing some concern and a pullback in shares.
Stock-Based CompensationClover discussed how its stock-based compensation will be drastically reduced beginning in 2026 with the final vesting of two founders grants, which accounted for more than half of the stock-based compensation expense in 2024 and expected in 2025.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was $2.12 and its highest was $4.87 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is $1.65B.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s upcoming earnings report date is Nov 10, 2025 which is in 45 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Aug 05, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.009 by -$0.011.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is -0.04.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 420,139,400 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.009. Following the earnings report the stock price went down -20.702%.
Which hedge fund is a major shareholder of Clover Health Investments?
Currently, no hedge funds are holding shares in CLOV
Clover Health Investments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.65 (15.51% Upside)
$3.65 (15.51% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 56.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.78%
12-Months-Change
Fundamentals
Return on Equity
-12.59%
Trailing 12-Months
Asset Growth
-14.72%
Trailing 12-Months
Company Description
Clover Health Investments
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
CLOV Company Deck
CLOV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Clover Health's earnings call highlighted significant membership and revenue growth, sustained profitability, and promising technological advancements, although challenges such as elevated costs and a GAAP net loss were noted. The outlook for 2026 remains positive with expected financial tailwinds.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$3.65
▲(15.51% Upside)
Technical Analysis
Ownership Overview
7.58% Insiders
6.11% Mutual Funds
1.61% Other Institutional Investors
73.96% Public Companies and
Individual Investors